This is a table of type trigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
trigram | frequency |
---|---|
stem cell transplantation | 1018 |
in patients with | 977 |
as well as | 721 |
hematopoietic stem cell | 645 |
the presence of | 528 |
conflict of interest | 514 |
of patients with | 493 |
disclosure of conflict | 479 |
of conflict of | 479 |
of the patients | 455 |
cd t cells | 454 |
the use of | 429 |
a total of | 346 |
the expression of | 323 |
the development of | 321 |
the role of | 319 |
in order to | 318 |
is associated with | 312 |
the most common | 306 |
there was no | 305 |
of this study | 301 |
in this study | 297 |
with a median | 294 |
the incidence of | 290 |
the aim of | 286 |
for patients with | 284 |
the time of | 276 |
nothing to declare | 275 |
study was to | 271 |
cd and cd | 270 |
the number of | 268 |
allogeneic hematopoietic stem | 266 |
the treatment of | 262 |
at the time | 261 |
is a rare | 239 |
a median of | 236 |
one of the | 236 |
the diagnosis of | 230 |
to evaluate the | 223 |
according to the | 222 |
in children with | 218 |
this study was | 217 |
was observed in | 216 |
was associated with | 216 |
years of age | 214 |
aim of this | 214 |
due to the | 209 |
the risk of | 204 |
associated with a | 202 |
the majority of | 202 |
allogeneic stem cell | 200 |
to determine the | 199 |
median age of | 192 |
patients who received | 187 |
the effect of | 187 |
were treated with | 185 |
stem cell transplant | 184 |
was found to | 183 |
the absence of | 183 |
a median follow | 180 |
by flow cytometry | 177 |
there were no | 174 |
the patient was | 173 |
versus host disease | 173 |
graft versus host | 172 |
found to be | 171 |
at a median | 171 |
based on the | 170 |
in the first | 170 |
the median age | 170 |
acute myeloid leukemia | 167 |
the impact of | 163 |
a patient with | 162 |
median age was | 161 |
was used to | 159 |
in all patients | 158 |
has not been | 157 |
in the presence | 157 |
there was a | 156 |
in terms of | 155 |
is the most | 154 |
in addition to | 152 |
morbidity and mortality | 152 |
cumulative incidence of | 151 |
a case of | 150 |
united states background | 148 |
in patients who | 148 |
cells in the | 146 |
a history of | 145 |
peripheral blood stem | 145 |
found to have | 144 |
of the disease | 144 |
role in the | 144 |
of these patients | 143 |
acute lymphoblastic leukemia | 143 |
cd t cell | 142 |
median time to | 142 |
the age of | 141 |
t cells and | 141 |
all patients received | 141 |
compared to the | 140 |
to assess the | 140 |
mg kg day | 139 |
autologous stem cell | 139 |
in the absence | 137 |
as compared to | 136 |
increased risk of | 135 |
the immune system | 133 |
we report a | 133 |
been shown to | 133 |
abstract case report | 132 |
patients with a | 132 |
median age at | 132 |
case report text | 132 |
be associated with | 131 |
the frequency of | 131 |
all patients were | 130 |
quality of life | 128 |
in response to | 128 |
to investigate the | 128 |
been associated with | 127 |
patients who underwent | 127 |
a variety of | 126 |
hematopoietic cell transplantation | 126 |
the median time | 126 |
in combination with | 125 |
should be considered | 125 |
the setting of | 124 |
we found that | 123 |
was diagnosed with | 123 |
in the setting | 123 |
there is no | 122 |
and in the | 122 |
the outcome of | 121 |
there is a | 121 |
are associated with | 121 |
were included in | 120 |
study is to | 119 |
the importance of | 119 |
of multiple sclerosis | 118 |
were associated with | 118 |
associated with the | 117 |
it has been | 117 |
of patients who | 117 |
age was years | 117 |
the most frequent | 116 |
t cells in | 116 |
the pathogenesis of | 116 |
was detected in | 115 |
in the literature | 115 |
is the first | 115 |
case of a | 115 |
included in the | 114 |
in pediatric patients | 114 |
for the treatment | 114 |
involved in the | 113 |
and cd t | 112 |
in the study | 112 |
was found in | 112 |
stem cell source | 112 |
pediatric patients with | 111 |
of the study | 111 |
total of patients | 111 |
in all cases | 111 |
the present study | 110 |
age of years | 109 |
a diagnosis of | 109 |
t cells were | 108 |
in the treatment | 107 |
of the immune | 107 |
the case of | 107 |
analysis of the | 107 |
an important role | 107 |
sickle cell disease | 107 |
bone marrow transplantation | 106 |
of t cells | 106 |
this is the | 106 |
has been shown | 105 |
the prevalence of | 104 |
the results of | 104 |
an increase in | 104 |
were used to | 104 |
of cd cells | 104 |
in a patient | 104 |
was treated with | 103 |
whole exome sequencing | 103 |
central nervous system | 102 |
is characterized by | 102 |
is one of | 102 |
patients treated with | 101 |
the control group | 101 |
the end of | 100 |
median time of | 99 |
was defined as | 99 |
from patients with | 99 |
expression of the | 99 |
was seen in | 99 |
risk factors for | 99 |
specific t cells | 98 |
the conditioning regimen | 98 |
acute and chronic | 98 |
mutations in the | 98 |
was performed in | 98 |
a median age | 98 |
shown to be | 97 |
patients in the | 97 |
have been reported | 97 |
of children with | 97 |
to be a | 97 |
in both groups | 96 |
median follow up | 96 |
and chronic gvhd | 96 |
we present a | 96 |
patients who had | 96 |
the level of | 96 |
of patients were | 95 |
at least one | 95 |
patients had a | 95 |
as a result | 94 |
of cd t | 94 |
was significantly higher | 94 |
in of patients | 94 |
for the first | 94 |
a role in | 94 |
has been reported | 93 |
median number of | 93 |
in of the | 93 |
year overall survival | 93 |
important role in | 93 |
at our institution | 93 |
to have a | 93 |
cohort of patients | 93 |
none of the | 92 |
risk factor for | 92 |
after allogeneic hematopoietic | 92 |
results suggest that | 92 |
this study is | 92 |
the need for | 92 |
are needed to | 91 |
we report the | 91 |
months of age | 90 |
in peripheral blood | 90 |
the efficacy of | 90 |
median of days | 89 |
the effects of | 89 |
a number of | 89 |
may be a | 89 |
in these patients | 88 |
majority of patients | 88 |
significantly higher in | 88 |
was started on | 88 |
were found to | 88 |
retrospective chart review | 88 |
were observed in | 87 |
and nk cells | 87 |
significantly associated with | 86 |
the patients with | 86 |
was to evaluate | 86 |
blood stem cells | 86 |
patients with high | 86 |
who did not | 85 |
up of months | 85 |
between january and | 85 |
at time of | 85 |
during the first | 85 |
reduced intensity conditioning | 85 |
before and after | 85 |
no significant difference | 84 |
after a median | 84 |
of t cell | 84 |
data suggest that | 84 |
all patients had | 84 |
with or without | 83 |
when compared to | 83 |
analysis was performed | 82 |
most of the | 82 |
seems to be | 82 |
we performed a | 82 |
patients who were | 82 |
gd t cells | 82 |
we show that | 82 |
the context of | 81 |
compared to those | 81 |
of the most | 81 |
part of the | 81 |
on the other | 81 |
the addition of | 81 |
at the age | 81 |
patients were treated | 80 |
and bone marrow | 80 |
the activation of | 80 |
in our center | 80 |
p disclosure of | 80 |
was no significant | 80 |
group of patients | 79 |
the course of | 79 |
well as the | 79 |
in contrast to | 79 |
high levels of | 79 |
of acute gvhd | 78 |
in multiple sclerosis | 78 |
number of cd | 78 |
with a history | 77 |
in the context | 77 |
the rate of | 77 |
between the two | 77 |
we aimed to | 77 |
patients with acute | 77 |
bone marrow failure | 77 |
the patients who | 77 |
been reported in | 77 |
the percentage of | 77 |
follow up of | 77 |
the first year | 77 |
memory b cells | 76 |
in the pathogenesis | 76 |
and overall survival | 76 |
expression of cd | 76 |
blood stem cell | 75 |
related to the | 75 |
of the cases | 75 |
was used in | 74 |
in our study | 74 |
number of patients | 74 |
was assessed by | 74 |
b cells and | 74 |
were diagnosed with | 74 |
we investigated the | 73 |
associated with increased | 73 |
a cohort of | 73 |
significant difference in | 73 |
were able to | 73 |
this is a | 73 |
the other hand | 72 |
to study the | 72 |
a year old | 72 |
were found in | 72 |
the production of | 72 |
play a role | 71 |
a result of | 71 |
of cd and | 71 |
increase in the | 71 |
the lack of | 71 |
the purpose of | 71 |
in case of | 71 |
the study was | 71 |
of b cells | 71 |
the patients were | 71 |
used as a | 70 |
patients received a | 70 |
at the end | 70 |
because of the | 70 |
be considered in | 70 |
was used for | 70 |
the united states | 69 |
was higher in | 69 |
can be used | 69 |
as part of | 69 |
was performed using | 69 |
a combination of | 69 |
can lead to | 69 |
found in the | 68 |
the bone marrow | 68 |
in the present | 68 |
neutrophil and platelet | 68 |
the management of | 68 |
matched unrelated donor | 68 |
to our knowledge | 68 |
was the most | 68 |
the combination of | 68 |
no evidence of | 68 |
t and b | 68 |
contribute to the | 68 |
the regulation of | 68 |
no difference in | 67 |
the induction of | 67 |
and treatment of | 67 |
the immune response | 67 |
cell transplantation in | 67 |
a retrospective study | 67 |
with and without | 67 |
aim of the | 67 |
median duration of | 67 |
were detected in | 67 |
all patients with | 66 |
cause of death | 66 |
report a case | 66 |
safety and efficacy | 66 |
the cumulative incidence | 66 |
used in the | 66 |
there are no | 66 |
t cell activation | 66 |
were positive for | 66 |
the onset of | 66 |
of the patient | 66 |
specific cd t | 65 |
to identify the | 65 |
we describe a | 65 |
observed in patients | 65 |
t cell receptor | 65 |
human immunodeficiency virus | 65 |
one patient with | 65 |
in one patient | 65 |
bone marrow transplant | 65 |
of our study | 64 |
due to a | 64 |
allogeneic hematopoietic cell | 64 |
no significant differences | 64 |
to be associated | 64 |
to determine whether | 64 |
severe combined immunodeficiency | 64 |
depending on the | 64 |
occurred in patients | 64 |
mutation in the | 64 |
with respect to | 64 |
in the development | 64 |
associated with an | 64 |
common variable immunodeficiency | 63 |
compared with the | 63 |
more likely to | 63 |
in vitro and | 63 |
standard of care | 63 |
we retrospectively analyzed | 63 |
for the development | 63 |
conditioning regimen was | 63 |
patients with scd | 63 |
out of patients | 63 |
is important to | 62 |
shown in table | 62 |
the first time | 62 |
did not have | 62 |
to compare the | 62 |
and platelet engraftment | 62 |
for treatment of | 62 |
regulatory t cells | 62 |
to declare background | 62 |
at years of | 62 |
herpes simplex virus | 62 |
the detection of | 62 |
polymerase chain reaction | 62 |
a median time | 61 |
to analyze the | 61 |
patients with severe | 61 |
the two groups | 61 |
t cell responses | 61 |
has been associated | 61 |
overall survival was | 61 |
was confirmed by | 61 |
is the only | 60 |
in complete remission | 60 |
the identification of | 60 |
reported in the | 60 |
prior to the | 60 |
was determined by | 60 |
in the group | 60 |
a group of | 60 |
from january to | 60 |
an increased risk | 60 |
a series of | 60 |
hematopoietic stem cells | 60 |
in situ hybridization | 59 |
the patient is | 59 |
the relationship between | 59 |
we hypothesized that | 59 |
in patients and | 59 |
observed in the | 59 |
the quality of | 59 |
s of s | 59 |
high risk of | 59 |
was performed by | 59 |
we conducted a | 59 |
suggest that the | 59 |
appears to be | 59 |
the occurrence of | 59 |
inflammatory bowel disease | 59 |
in the control | 58 |
peripheral blood mononuclear | 58 |
the possibility of | 58 |
a dose of | 58 |
after the first | 58 |
been described in | 58 |
studies are needed | 58 |
the patient had | 58 |
bone marrow biopsy | 58 |
significant differences in | 58 |
age at diagnosis | 58 |
compared to patients | 58 |
old male with | 58 |
resulted in a | 58 |
clinical and laboratory | 58 |
for all patients | 58 |
all of them | 57 |
chronic granulomatous disease | 57 |
the most important | 57 |
and the patient | 57 |
blood mononuclear cells | 57 |
was diagnosed in | 57 |
have been described | 57 |
was present in | 57 |
in this patient | 57 |
aim was to | 57 |
patients with multiple | 57 |
the ability of | 57 |
intensive care unit | 57 |
at our center | 57 |
we evaluated the | 56 |
we observed that | 56 |
may lead to | 56 |
known to be | 56 |
to describe the | 56 |
died due to | 56 |
activation of the | 56 |
have shown that | 56 |
of the virus | 56 |
in the united | 56 |
end of the | 56 |
here we report | 56 |
have not been | 56 |
dose of mg | 56 |
with a high | 55 |
acute kidney injury | 55 |
at the same | 55 |
was performed on | 55 |
we present the | 55 |
diffuse large b | 55 |
and efficacy of | 55 |
the median follow | 55 |
risk of developing | 55 |
the analysis of | 55 |
a retrospective chart | 55 |
was performed with | 55 |
purpose of this | 55 |
total body irradiation | 55 |
it is important | 55 |
it is not | 55 |
is an important | 55 |
understanding of the | 55 |
t cells from | 55 |
the proportion of | 54 |
is a common | 54 |
was referred to | 54 |
to reduce the | 54 |
is caused by | 54 |
failure to thrive | 54 |
mhc class i | 54 |
of chronic gvhd | 54 |
the first days | 54 |
of the first | 54 |
the association between | 54 |
higher in the | 54 |
of patients had | 54 |
patients were included | 54 |
t cells with | 54 |
adult patients with | 54 |
in children and | 54 |
with sickle cell | 54 |
need to be | 54 |
barr virus infection | 54 |
myeloablative conditioning regimen | 53 |
not associated with | 53 |
further studies are | 53 |
in comparison with | 53 |
in comparison to | 53 |
were used for | 53 |
not statistically significant | 53 |
umbilical cord blood | 53 |
in cases of | 53 |
of the skin | 53 |
the overall survival | 53 |
the outcomes of | 53 |
is involved in | 53 |
was used as | 53 |
compared to healthy | 53 |
play an important | 53 |
full donor chimerism | 53 |
to declare p | 53 |
differences in the | 52 |
with multiple myeloma | 52 |
may contribute to | 52 |
the differential diagnosis | 52 |
of the tumor | 52 |
of stem cells | 52 |
incidence of acute | 52 |
in association with | 52 |
we observed a | 52 |
one patient had | 52 |
the only curative | 52 |
were enrolled in | 52 |
and the other | 52 |
could not be | 52 |
the type of | 52 |
this study we | 52 |
haematopoietic stem cell | 52 |
in our cohort | 52 |
are shown in | 51 |
changes in the | 51 |
the generation of | 51 |
and management of | 51 |
the objective of | 51 |
has been described | 51 |
of all patients | 51 |
we analyzed the | 51 |
at months of | 51 |
in the last | 51 |
of bone marrow | 51 |
as gvhd prophylaxis | 51 |
the start of | 51 |
old female with | 51 |
the duration of | 51 |
little is known | 51 |
squamous cell carcinoma | 51 |
the t cell | 51 |
was no difference | 51 |
incidence of relapse | 51 |
this retrospective study | 51 |
in a single | 51 |
cd cd cd | 51 |
be used to | 51 |
is based on | 51 |
the mean age | 51 |
no statistically significant | 50 |
a decrease in | 50 |
all of the | 50 |
was significantly lower | 50 |
only one patient | 50 |
and b cells | 50 |
national institute of | 50 |
minimal residual disease | 50 |
included in this | 50 |
who presented with | 50 |
was carried out | 50 |
did not receive | 50 |
a subset of | 50 |
have been shown | 50 |
and one patient | 50 |
at a dose | 50 |
has been used | 50 |
after allogeneic stem | 50 |
in multivariate analysis | 49 |
the function of | 49 |
performed a retrospective | 49 |
patients with primary | 49 |
the first case | 49 |
be due to | 49 |
be involved in | 49 |
of them were | 49 |
of allogeneic hematopoietic | 49 |
in patients undergoing | 49 |
iv acute gvhd | 49 |
to be the | 49 |
objective of this | 49 |
the degree of | 49 |
in the patient | 49 |
patient is a | 49 |
and mortality in | 49 |
was identified in | 49 |
chronic gvhd was | 49 |
median time from | 49 |
higher incidence of | 49 |
patients diagnosed with | 48 |
the activity of | 48 |
the fact that | 48 |
of nk cells | 48 |
and patients with | 48 |
from peripheral blood | 48 |
in the patients | 48 |
member of the | 48 |
the surface of | 48 |
the mechanism of | 48 |
time to neutrophil | 48 |
is known about | 47 |
such as the | 47 |
the group of | 47 |
cd cell dose | 47 |
higher risk of | 47 |
were used as | 47 |
retrospective analysis of | 47 |
present a case | 47 |
the peripheral blood | 47 |
were significantly higher | 47 |
and safety of | 47 |
difference in the | 47 |
in the case | 47 |
the median number | 47 |
after hematopoietic stem | 47 |
did not show | 47 |
next generation sequencing | 47 |
our data suggest | 47 |
we found a | 47 |
patients are alive | 47 |
in this population | 47 |
in the majority | 46 |
review of the | 46 |
we conclude that | 46 |
a case report | 46 |
t cell proliferation | 46 |
a risk factor | 46 |
chart review of | 46 |
the amount of | 46 |
in the early | 46 |
the same time | 46 |
acute gvhd was | 46 |
were divided into | 46 |
was evaluated by | 46 |
a single center | 46 |
the severity of | 46 |
for patients who | 46 |
the progression of | 46 |
in the pediatric | 46 |
differential diagnosis of | 46 |
age at transplant | 46 |
during the study | 46 |
the study period | 46 |
and mycophenolate mofetil | 46 |
and may be | 46 |
is needed to | 46 |
showed that the | 46 |
was able to | 45 |
samples were collected | 45 |
has also been | 45 |
levels of il | 45 |
patients were transplanted | 45 |
is required for | 45 |
patients who developed | 45 |
of peripheral blood | 45 |
and young adults | 45 |
patients with aml | 45 |
and in vivo | 45 |
the cells were | 45 |
and t cell | 45 |
was achieved in | 45 |
in of cases | 45 |
report text introduction | 45 |
median age years | 45 |
age of the | 45 |
present in the | 45 |
a statistically significant | 45 |
remains to be | 45 |
half of the | 44 |
in our series | 44 |
with high risk | 44 |
of morbidity and | 44 |
and of the | 44 |
likely to be | 44 |
the levels of | 44 |
be related to | 44 |
did not differ | 44 |
of cd cd | 44 |
was to determine | 44 |
with a mean | 44 |
progression free survival | 44 |
is a major | 44 |
the ability to | 44 |
the day of | 44 |
responsible for the | 44 |
autologous hematopoietic stem | 44 |
males and females | 44 |
in our patient | 44 |
the patients had | 44 |
a significant increase | 44 |
red blood cell | 44 |
the median duration | 43 |
barr virus in | 43 |
are involved in | 43 |
the influence of | 43 |
memory t cells | 43 |
used for the | 43 |
when compared with | 43 |
were performed in | 43 |
organ transplant recipients | 43 |
out of the | 43 |
in this cohort | 43 |
with history of | 43 |
mean age of | 43 |
was consistent with | 43 |
to patients with | 43 |
of the human | 43 |
may be associated | 43 |
significantly lower in | 43 |
history of recurrent | 43 |
was admitted to | 43 |
significantly higher than | 43 |
and multiple sclerosis | 43 |
increased susceptibility to | 43 |
in relation to | 43 |
patients were in | 43 |
we did not | 43 |
or chronic gvhd | 43 |
is known to | 43 |
to determine if | 43 |
led to the | 42 |
we hypothesize that | 42 |
multiple sclerosis in | 42 |
led to a | 42 |
more than of | 42 |
the safety and | 42 |
results indicate that | 42 |
significant increase in | 42 |
described in the | 42 |
vg vd t | 42 |
one patient developed | 42 |
there have been | 42 |
and can be | 42 |
the basis of | 42 |
between the groups | 42 |
in the regulation | 42 |
be used as | 42 |
and after the | 42 |
in the second | 42 |
of patients in | 42 |
a retrospective analysis | 42 |
aim of our | 42 |
high incidence of | 42 |
have been associated | 42 |
the administration of | 42 |
was shown to | 42 |
were analyzed by | 42 |
cause of morbidity | 42 |
cell transplantation for | 42 |
in patients receiving | 42 |
patient with a | 42 |
be considered as | 42 |
is essential for | 42 |
were used in | 42 |
in t cells | 42 |
been reported to | 42 |
family history of | 42 |
acute gvhd grade | 42 |
systemic lupus erythematosus | 42 |
to understand the | 42 |
correlation between the | 42 |
the general population | 41 |
acute or chronic | 41 |
after the outbreak | 41 |
during the outbreak | 41 |
of the breast | 41 |
we sought to | 41 |
in a large | 41 |
detected in the | 41 |
in this case | 41 |
was measured by | 41 |
and b cell | 41 |
followed by a | 41 |
role of the | 41 |
these results suggest | 41 |
and cd cd | 41 |
of the liver | 41 |
have been identified | 41 |
for children with | 41 |
vitro and in | 41 |
statistically significant difference | 41 |
in the differential | 41 |
a member of | 41 |
to the development | 41 |
months after hsct | 41 |
was performed to | 41 |
one patient died | 41 |
one or more | 40 |
within the first | 40 |
correlated with the | 40 |
a prospective study | 40 |
was to investigate | 40 |
our aim was | 40 |
data indicate that | 40 |
from to years | 40 |
the evaluation of | 40 |
of a patient | 40 |
our results suggest | 40 |
a marker of | 40 |
respiratory tract infections | 40 |
the tumor cells | 40 |
of cmv reactivation | 40 |
matched sibling donor | 40 |
t cells are | 40 |
patients with relapsed | 40 |
bone marrow and | 40 |
red blood cells | 40 |
b and t | 40 |
at last follow | 40 |
acute graft versus | 40 |
our study was | 40 |
all the patients | 40 |
cd cells were | 40 |
and the median | 40 |
but not in | 40 |
major cause of | 40 |
is an effective | 40 |
enrolled in the | 40 |
infection in the | 40 |
were no significant | 40 |
findings suggest that | 39 |
of hematopoietic stem | 39 |
at high risk | 39 |
we aim to | 39 |
presence of a | 39 |
increased expression of | 39 |
treatment option for | 39 |
mg m day | 39 |
engraftment was days | 39 |
and it is | 39 |
diagnosis and treatment | 39 |
children and adolescents | 39 |
was negative for | 39 |
was to assess | 39 |
of our patients | 39 |
outcome of patients | 39 |
in our institution | 39 |
their ability to | 39 |
the cause of | 39 |
the association of | 39 |
compared to controls | 39 |
the stem cell | 39 |
patients with mm | 39 |
patient had a | 39 |
are the most | 39 |
cell source was | 39 |
well as in | 38 |
not significantly different | 38 |
development of a | 38 |
factors associated with | 38 |
were identified in | 38 |
at day and | 38 |
the incidence and | 38 |
are able to | 38 |
secondary graft failure | 38 |
neutrophil engraftment was | 38 |
associated with higher | 38 |
b cell lymphoma | 38 |
and peripheral blood | 38 |
a role for | 38 |
higher in patients | 38 |
patients with hematological | 38 |
and did not | 38 |
in the past | 38 |
and cd cells | 38 |
of stem cell | 38 |
lower respiratory tract | 38 |
a period of | 38 |
patients were diagnosed | 38 |
time of the | 38 |
presented with a | 38 |
mean age was | 38 |
of the clinical | 38 |
extensive chronic gvhd | 38 |
in t cell | 38 |
of them had | 38 |
chronic kidney disease | 38 |
one of them | 38 |
needs to be | 38 |
to characterize the | 38 |
in those with | 38 |
serum levels of | 38 |
we demonstrate that | 38 |
of the cd | 38 |
conducted a retrospective | 38 |
of which were | 38 |
delta t cells | 38 |
leading to the | 38 |
with regard to | 38 |
at the university | 38 |
were detected by | 38 |
mean age at | 38 |
school of medicine | 38 |
prophylaxis consisted of | 38 |
efficacy and safety | 37 |
proportion of patients | 37 |
were the most | 37 |
of age with | 37 |
blood samples were | 37 |
evaluation of the | 37 |
two patients with | 37 |
of pediatric patients | 37 |
prior to hsct | 37 |
of the following | 37 |
of patients and | 37 |
who received a | 37 |
of the viral | 37 |
gene expression in | 37 |
impact on the | 37 |
the last years | 37 |
children with scd | 37 |
at years was | 37 |
flow cytometry and | 37 |
fludarabine mg m | 37 |
more common in | 37 |
in some cases | 37 |
disease status at | 37 |
in pts with | 37 |
with an increased | 37 |
in b cells | 37 |
with hematological malignancies | 37 |
some of the | 37 |
medical records of | 37 |
carcinoma of the | 37 |
low levels of | 37 |
time of diagnosis | 37 |
in the two | 37 |
on the basis | 37 |
is to evaluate | 37 |
to that of | 37 |
we were able | 37 |
to improve the | 37 |
higher levels of | 37 |
the central nervous | 37 |
in the diagnosis | 37 |
t cell development | 37 |
the study of | 37 |
of b cell | 37 |
with multiple sclerosis | 37 |
data were collected | 37 |
were obtained from | 37 |
caused by a | 36 |
cytotoxic t cells | 36 |
is not well | 36 |
combined immune deficiency | 36 |
the probability of | 36 |
from healthy donors | 36 |
cell proliferation and | 36 |
hla class i | 36 |
among patients with | 36 |
in univariate analysis | 36 |
to play a | 36 |
institutes of health | 36 |
and the presence | 36 |
of acute and | 36 |
data on the | 36 |
on the surface | 36 |
was performed and | 36 |
transplant related mortality | 36 |
the etiology of | 36 |
barr virus and | 36 |
for the diagnosis | 36 |
main cause of | 36 |
patients suffering from | 36 |
in which the | 36 |
to define the | 36 |
national institutes of | 36 |
or absence of | 36 |
the efficacy and | 36 |
by western blot | 36 |
all patients who | 36 |
of the two | 36 |
from diagnosis to | 36 |
of mg kg | 36 |
followed by autologous | 36 |
in the same | 36 |
urinary tract infection | 36 |
with the use | 36 |
were measured by | 36 |
leading cause of | 36 |
and severity of | 36 |
of the same | 36 |
os and pfs | 36 |
the formation of | 35 |
more frequent in | 35 |
results of the | 35 |
thought to be | 35 |
show that the | 35 |
more than one | 35 |
successfully treated with | 35 |
increased risk for | 35 |
renal transplant recipients | 35 |
defined as the | 35 |
to the hospital | 35 |
than in the | 35 |
class i molecules | 35 |
for gvhd prophylaxis | 35 |
in two patients | 35 |
we developed a | 35 |
for more than | 35 |
significant difference between | 35 |
we showed that | 35 |
a significantly higher | 35 |
t cells was | 35 |
to explore the | 35 |
at risk for | 35 |
the introduction of | 35 |
any of the | 35 |
safe and effective | 35 |
obtained from the | 35 |
retrospective review of | 35 |
immunoglobulin replacement therapy | 35 |
resulting in a | 35 |
in the number | 35 |
response to treatment | 35 |
proved to be | 35 |
which can be | 35 |
platelet engraftment was | 35 |
to increase the | 35 |
hsct in our | 35 |
causes of death | 35 |
it can be | 35 |
primary immune deficiency | 35 |
summarized in table | 35 |
are known to | 35 |
antigen presenting cells | 35 |
haploidentical stem cell | 35 |
in the peripheral | 35 |
risk of ms | 35 |
was not significantly | 35 |
were determined by | 35 |
the release of | 34 |
of patients was | 34 |
with bone marrow | 34 |
seen in the | 34 |
test was used | 34 |
study was conducted | 34 |
patients who did | 34 |
were isolated from | 34 |
blood and marrow | 34 |
in bone marrow | 34 |
was not statistically | 34 |
cells and the | 34 |
who underwent hsct | 34 |
t cell response | 34 |
patients with cgd | 34 |
in this setting | 34 |
samples from patients | 34 |
in out of | 34 |
for at least | 34 |
the cell surface | 34 |
car t cells | 34 |
we have previously | 34 |
with a higher | 34 |
due to its | 34 |
status of the | 34 |
an average of | 34 |
characterized by a | 34 |
matched related donor | 34 |
moderate to severe | 34 |
was complicated by | 34 |
with acute myeloid | 34 |
specific t cell | 34 |
high rate of | 34 |
the tumor was | 34 |
and has been | 34 |
was performed for | 34 |
are alive and | 34 |
were collected from | 34 |
donor lymphocyte infusion | 34 |
in group a | 34 |
the extent of | 34 |
the remaining patients | 34 |
consistent with the | 34 |
a significant reduction | 34 |
stem cell mobilization | 34 |
in the future | 34 |
up to of | 34 |
of cases of | 33 |
it is a | 33 |
he was diagnosed | 33 |
stem cells in | 33 |
of the left | 33 |
overall survival in | 33 |
a matched unrelated | 33 |
in a cohort | 33 |
the loss of | 33 |
risk of relapse | 33 |
in the lung | 33 |
melphalan mg m | 33 |
and number of | 33 |
peripheral blood in | 33 |
it is possible | 33 |
who underwent allo | 33 |
report text background | 33 |
up was months | 33 |
expression in the | 33 |
these data suggest | 33 |
response to the | 33 |
members of the | 33 |
caused by mutations | 33 |
to examine the | 33 |
studies have shown | 33 |
magnetic resonance imaging | 33 |
gvhd prophylaxis consisted | 33 |
autoimmune hemolytic anemia | 33 |
we retrospectively reviewed | 33 |
a panel of | 33 |
for these patients | 33 |
in the liver | 33 |
the main cause | 33 |
to healthy controls | 33 |
cd cells kg | 33 |
was analyzed by | 33 |
t cell lymphopenia | 33 |
that can be | 33 |
b cells in | 33 |
and response to | 33 |
in group b | 33 |
in the general | 33 |
the gastrointestinal tract | 33 |
a bone marrow | 33 |
the process of | 33 |
patients who are | 32 |
study aimed to | 32 |
majority of the | 32 |
the reaction norm | 32 |
disease free survival | 32 |
the contribution of | 32 |
b cells were | 32 |
our understanding of | 32 |
at that time | 32 |
year os was | 32 |
among the patients | 32 |
were no differences | 32 |
cd cells in | 32 |
age of patients | 32 |
nature of the | 32 |
an increase of | 32 |
from the same | 32 |
are required to | 32 |
the first months | 32 |
a critical role | 32 |
here we present | 32 |
cell transplantation is | 32 |
adverse events were | 32 |
considered as a | 32 |
option for patients | 32 |
was well tolerated | 32 |
found in patients | 32 |
the significance of | 32 |
which is a | 32 |
of patients undergoing | 32 |
acute gvhd and | 32 |
located in the | 32 |
presence or absence | 32 |
clinical features of | 32 |
severe chronic gvhd | 32 |
in the immune | 32 |
the control of | 32 |
two patients had | 32 |
the current study | 32 |
serve as a | 32 |
there is an | 32 |
similar to the | 32 |
the spectrum of | 32 |
was based on | 32 |
appear to be | 32 |
referred to our | 32 |
of the t | 32 |
conditioning regimen for | 32 |
follow up was | 32 |
patients undergoing allogeneic | 32 |
recurrent sinopulmonary infections | 32 |
of vitamin d | 32 |
an unrelated donor | 32 |
we studied the | 32 |
ranged from to | 32 |
differences between the | 32 |
and outcomes of | 32 |
at transplant was | 32 |
it should be | 32 |
with acute leukemia | 32 |
is a frequent | 32 |
the plasma membrane | 32 |
patients with chronic | 32 |
a reduction in | 32 |
solid organ transplant | 32 |
with newly diagnosed | 31 |
performed in patients | 31 |
was peripheral blood | 31 |
patients with pid | 31 |
abdominal pain and | 31 |
patients with sickle | 31 |
were classified as | 31 |
and lack of | 31 |
t cells to | 31 |
results demonstrate that | 31 |
gvhd prophylaxis was | 31 |
may be an | 31 |
at a single | 31 |
we compared the | 31 |
cd cd cells | 31 |
in immunocompromised patients | 31 |
results showed that | 31 |
in recent years | 31 |
cd cell count | 31 |
were evaluated by | 31 |
a child with | 31 |
single center experience | 31 |
significant impact on | 31 |
the most commonly | 31 |
no differences in | 31 |
with median age | 31 |
a primary immunodeficiency | 31 |
plays an important | 31 |
year old male | 31 |
by mutations in | 31 |
he was treated | 31 |
those who did | 31 |
it may be | 31 |
was positive for | 31 |
were performed using | 31 |
in our centre | 31 |
primary graft failure | 31 |
is a well | 31 |
divided into two | 31 |
iga and igm | 31 |
tumor cells were | 31 |
the potential to | 31 |
balb c mice | 31 |
were tested for | 31 |
were more likely | 31 |
on days and | 31 |
chronic graft versus | 31 |
cells of the | 31 |
is thought to | 31 |
a and b | 31 |
may not be | 31 |
prior to and | 31 |
characteristics of the | 31 |
the patient and | 31 |
interstitial lung disease | 31 |
male and female | 31 |
tumor necrosis factor | 31 |
analyses were performed | 31 |
these patients were | 31 |
activated t cells | 31 |
white blood cell | 31 |
statistical analysis was | 31 |
bone marrow in | 30 |
the rest of | 30 |
to be an | 30 |
found that the | 30 |
presence of the | 30 |
ranging from to | 30 |
with a diagnosis | 30 |
patients from the | 30 |
the diagnosis and | 30 |
characterized by the | 30 |
length of stay | 30 |
latent membrane protein | 30 |
mhc class ii | 30 |
after allogeneic hsct | 30 |
patients with low | 30 |
results show that | 30 |
we describe the | 30 |
immune response to | 30 |
present the case | 30 |
chart review was | 30 |
on day and | 30 |
course of the | 30 |
with the same | 30 |
in the right | 30 |
donor lymphocyte infusions | 30 |
was supported by | 30 |
a consequence of | 30 |
the presence or | 30 |
switched memory b | 30 |
patients with agvhd | 30 |
in more than | 30 |
is dependent on | 30 |
have been used | 30 |
high dose chemotherapy | 30 |
to better understand | 30 |
after initiation of | 30 |
the innate immune | 30 |
a trend towards | 30 |
b and nk | 30 |
the most frequently | 30 |
the site of | 30 |
seen in patients | 30 |
we have identified | 30 |
was evaluated in | 30 |
peripheral blood of | 30 |
after days of | 30 |
all patients engrafted | 30 |
were compared to | 30 |
sensitivity and specificity | 30 |
after stem cell | 30 |
a crucial role | 30 |
over the last | 30 |
the patients was | 30 |
of allergy and | 30 |
patients who have | 30 |
patients undergoing hsct | 30 |
the result of | 30 |
lead to a | 30 |
we examined the | 30 |
regulation of the | 30 |
who underwent allogeneic | 30 |
absolute neutrophil count | 30 |
clinical trial registry | 30 |
the correlation between | 30 |
cell lines and | 30 |
were reported in | 30 |
of viral infections | 30 |
we report our | 30 |
lead to the | 29 |
with the development | 29 |
to confirm the | 29 |
faculty of medicine | 29 |
function of the | 29 |
in the blood | 29 |
incidence of grade | 29 |
prior to transplant | 29 |
derived from the | 29 |
of the present | 29 |
the distribution of | 29 |
a retrospective review | 29 |
for min at | 29 |
could be a | 29 |
is a primary | 29 |
with primary immunodeficiency | 29 |
viral infections and | 29 |
and nk cell | 29 |
of primary immunodeficiency | 29 |
was a significant | 29 |
associated with high | 29 |
overall survival of | 29 |
can be a | 29 |
patient was diagnosed | 29 |
acute chest syndrome | 29 |
sinusoidal obstruction syndrome | 29 |
of the literature | 29 |
were transplanted in | 29 |
detected in patients | 29 |
in our experience | 29 |
the patients received | 29 |
at increased risk | 29 |
the dose of | 29 |
she was diagnosed | 29 |
to the best | 29 |
retrospective study of | 29 |
in both cases | 29 |
effect on the | 29 |
seem to be | 29 |
significant differences between | 29 |
induction of the | 29 |
is a very | 29 |
matched unrelated donors | 29 |
the cases of | 29 |
was to analyze | 29 |
and infectious diseases | 29 |
and had a | 29 |
was significantly associated | 29 |
patients with non | 29 |
no history of | 29 |
in adult patients | 29 |
at risk of | 29 |
we have shown | 29 |
was significant for | 29 |
in this group | 29 |
a review of | 29 |
and duration of | 29 |
may have a | 29 |
in patients treated | 29 |
regimen consisted of | 29 |
cells can be | 29 |
of breast cancer | 29 |
the first month | 29 |
difference between the | 29 |
first year of | 29 |
overall response rate | 29 |
respiratory syncytial virus | 29 |
at diagnosis was | 29 |
of death in | 29 |
in this retrospective | 29 |
patients did not | 29 |
the cd cd | 29 |
the patients in | 29 |
prior to transplantation | 29 |
results in a | 29 |
the clinical and | 29 |
demonstrated that the | 29 |
the results were | 28 |
were analyzed using | 28 |
large b cell | 28 |
on day was | 28 |
and disease free | 28 |
were significantly lower | 28 |
we suggest that | 28 |
risk of multiple | 28 |
study was performed | 28 |
data show that | 28 |
in the bone | 28 |
study of the | 28 |
were not significantly | 28 |
the response to | 28 |
a major cause | 28 |
conflicts of interest | 28 |
may result in | 28 |
risk factors and | 28 |
conditioning regimens were | 28 |
to our hospital | 28 |
days after the | 28 |
the increase in | 28 |
by means of | 28 |
a high risk | 28 |
patient was started | 28 |
in recipients of | 28 |
continued to have | 28 |
activity of the | 28 |
its role in | 28 |
depends on the | 28 |
cord blood transplantation | 28 |
chronic gvhd and | 28 |
the diagnosis was | 28 |
was obtained from | 28 |
and healthy controls | 28 |
could be used | 28 |
on day of | 28 |
of these two | 28 |
igg mg dl | 28 |
head and neck | 28 |
of cmv infection | 28 |
according to our | 28 |
nk cells were | 28 |
as a marker | 28 |
is mediated by | 28 |
than that of | 28 |
implicated in the | 28 |
colony stimulating factor | 28 |
are summarized in | 28 |
were in complete | 28 |
the study group | 28 |
and months after | 28 |
cytotoxic t lymphocytes | 28 |
considered to be | 28 |
patients were followed | 28 |
been implicated in | 28 |
as shown in | 28 |
total number of | 28 |
that may be | 28 |
vd t cells | 28 |
and t cells | 28 |
addition to the | 28 |
has to be | 28 |
high level of | 28 |
mesenchymal stem cells | 28 |
or in combination | 28 |
was reported in | 28 |
days after hsct | 28 |
a mutation in | 27 |
we assessed the | 27 |
also known as | 27 |
infections in the | 27 |
for the presence | 27 |
complete resolution of | 27 |
a significant difference | 27 |
pediatric oncology patients | 27 |
high risk patients | 27 |
in line with | 27 |
higher than the | 27 |
similar to that | 27 |
the goal of | 27 |
and in patients | 27 |
which may be | 27 |
was detected by | 27 |
in transplant recipients | 27 |
in a dose | 27 |
do not have | 27 |
relapsed or refractory | 27 |
cytokine release syndrome | 27 |
group compared to | 27 |
reported to be | 27 |
be used in | 27 |
was not associated | 27 |
she was started | 27 |
was notable for | 27 |
t cells by | 27 |
the patient with | 27 |
approved by the | 27 |
and for the | 27 |
the initiation of | 27 |
in cases with | 27 |
often associated with | 27 |
between and years | 27 |
been identified in | 27 |
on day after | 27 |
in accordance with | 27 |
of overall survival | 27 |
survival in patients | 27 |
common cause of | 27 |
boys and girls | 27 |
a cause of | 27 |
cd b cells | 27 |
significant decrease in | 27 |
noted to have | 27 |
during the follow | 27 |
considered in the | 27 |
in the post | 27 |
were negative for | 27 |
the patient underwent | 27 |
likely to have | 27 |
primary immunodeficiency diseases | 27 |
were compared with | 27 |
developed acute gvhd | 27 |
pediatric hematology oncology | 27 |
the median of | 27 |
biopsy of the | 27 |
it is also | 27 |
the utility of | 27 |
as a consequence | 27 |
use of a | 27 |
may play a | 27 |
patients compared to | 27 |
report the case | 27 |
of ebv in | 27 |
the application of | 27 |
and treated with | 27 |
of grade ii | 27 |
for the patients | 27 |
statistically significant differences | 27 |
for high risk | 27 |
of unknown significance | 27 |
has been demonstrated | 27 |
he was found | 27 |
had at least | 27 |
is a potentially | 27 |
describe a case | 27 |
an autosomal recessive | 27 |
in patients without | 27 |
the entire cohort | 27 |
of uncertain significance | 27 |
did not reach | 27 |
from unrelated donors | 27 |
with high dose | 26 |
occurred in the | 26 |
overall survival and | 26 |
one patient was | 26 |
to detect the | 26 |
and quality of | 26 |
were significantly increased | 26 |
cells infected with | 26 |
between patients with | 26 |
which has been | 26 |
after months of | 26 |
of these cells | 26 |
a key role | 26 |
of the total | 26 |
this case highlights | 26 |
be able to | 26 |
in the other | 26 |
used in patients | 26 |
is a significant | 26 |
may be used | 26 |
patients were enrolled | 26 |
based on these | 26 |
features of the | 26 |
the risk for | 26 |
in the course | 26 |
that of the | 26 |
that have been | 26 |
the development and | 26 |
were conditioned with | 26 |
disease caused by | 26 |
of treatment with | 26 |
time from diagnosis | 26 |
the pediatric population | 26 |
of the cells | 26 |
significant difference was | 26 |
we propose that | 26 |
known about the | 26 |
in the tumor | 26 |
as measured by | 26 |
production of il | 26 |
for the detection | 26 |
of death were | 26 |
this was a | 26 |
innate and adaptive | 26 |
severe aplastic anemia | 26 |
has been suggested | 26 |
d and d | 26 |
showed a significant | 26 |
biopsy was performed | 26 |
is difficult to | 26 |
patients had received | 26 |
a significant decrease | 26 |
of patients treated | 26 |
received myeloablative conditioning | 26 |
associated hemophagocytic lymphohistiocytosis | 26 |
univariate and multivariate | 26 |
as a potential | 26 |
in the non | 26 |
for multiple sclerosis | 26 |
were analyzed with | 26 |
was years old | 26 |
two cases of | 26 |
of the ebv | 26 |
identified in the | 26 |
specific cytotoxic t | 26 |
best of our | 26 |
t cell counts | 26 |
on the day | 26 |
used to compare | 26 |
in breast cancer | 26 |
and at the | 26 |
shown that the | 26 |
the best of | 26 |
reduction in the | 26 |
of this disease | 26 |
cd cd ra | 26 |
with no evidence | 26 |
our results show | 26 |
and stem cell | 26 |
of infectious complications | 26 |
of tumor cells | 26 |
conditioning regimen consisted | 26 |
small number of | 26 |
at months after | 26 |
revealed that the | 26 |
at this time | 26 |
immune system and | 26 |
of our knowledge | 26 |
or in the | 26 |
these results demonstrate | 26 |
source of stem | 26 |
protective effect of | 26 |
were present in | 26 |
different time points | 26 |
estimates of genetic | 26 |
in the management | 25 |
treated with a | 25 |
loss of function | 25 |
related mortality was | 25 |
the concentration of | 25 |
there has been | 25 |
mg kg on | 25 |
of patients are | 25 |
the university of | 25 |
virus infection in | 25 |
the establishment of | 25 |
patients with refractory | 25 |
the pi k | 25 |
to elucidate the | 25 |
the interaction of | 25 |
varicella zoster virus | 25 |
january and december | 25 |
two of the | 25 |
significantly different between | 25 |
of the il | 25 |
used to evaluate | 25 |
developed chronic gvhd | 25 |
leading to a | 25 |
only a few | 25 |
january to december | 25 |
consistent with a | 25 |
the availability of | 25 |
patient was treated | 25 |
is possible that | 25 |
of ebv infection | 25 |
well as a | 25 |
diagnosis and management | 25 |
caused by the | 25 |
patients with the | 25 |
the study is | 25 |
cells with a | 25 |
of immune dysregulation | 25 |
patient presented with | 25 |
to describe a | 25 |
investigate the role | 25 |
a higher risk | 25 |
time of transplant | 25 |
patients with no | 25 |
to of patients | 25 |
and viral infections | 25 |
the involvement of | 25 |
series of patients | 25 |
t cell depletion | 25 |
to respond to | 25 |
impact of the | 25 |
the first report | 25 |
upper respiratory tract | 25 |
heterozygous mutation in | 25 |
hepatitis b virus | 25 |
and outcome of | 25 |
patients with recurrent | 25 |
in cases and | 25 |
critical role in | 25 |
or bone marrow | 25 |
effect of the | 25 |
groups of patients | 25 |
allergy and infectious | 25 |
a reduced intensity | 25 |
referred to as | 25 |
institute of allergy | 25 |
i and ii | 25 |
no effect on | 25 |
without evidence of | 25 |
in the cd | 25 |
in most cases | 25 |
a part of | 25 |
has been observed | 25 |
patients have been | 25 |
index of suspicion | 25 |
th and th | 25 |
infected b cells | 25 |
the value of | 25 |
of consecutive patients | 25 |
to be effective | 25 |
in patients at | 25 |
different types of | 25 |
we demonstrated that | 25 |
cell activation and | 25 |
will be presented | 25 |
of graft failure | 25 |
cells in vitro | 25 |
in the thymus | 25 |
of the right | 24 |
inhibition of the | 24 |
severe acute respiratory | 24 |
incidence of chronic | 24 |
no conflict of | 24 |
the cost of | 24 |
and function of | 24 |
diseases such as | 24 |
donor t cells | 24 |
she was treated | 24 |
been shown that | 24 |
consecutive patients who | 24 |
of inkt cells | 24 |
report our experience | 24 |
of the lung | 24 |
had a significantly | 24 |
an effective treatment | 24 |
the nature of | 24 |
in exon of | 24 |
with r r | 24 |
course was complicated | 24 |
mg m on | 24 |
groups according to | 24 |
is consistent with | 24 |
the risk factors | 24 |
was noted in | 24 |
between and at | 24 |
differences were observed | 24 |
the source of | 24 |
median cd cell | 24 |
better understand the | 24 |
that it is | 24 |
recurrent infections and | 24 |
into two groups | 24 |
unrelated cord blood | 24 |
patients had an | 24 |
months after transplantation | 24 |
report of a | 24 |
cd t lymphocytes | 24 |
of the conditioning | 24 |
cells have been | 24 |
nk cells and | 24 |
cells as well | 24 |
can result in | 24 |
is safe and | 24 |
and the number | 24 |
defects in the | 24 |
is a life | 24 |
was positive in | 24 |
cells were positive | 24 |
is not a | 24 |
patients with advanced | 24 |
mg m d | 24 |
in a variety | 24 |
in solid organ | 24 |
and development of | 24 |
in the current | 24 |
with the presence | 24 |
reactive oxygen species | 24 |
mean number of | 24 |
the difference was | 24 |
the interaction between | 24 |
to be more | 24 |
three patients with | 24 |
is expressed in | 24 |
used to determine | 24 |
were seen in | 24 |
a safe and | 24 |
analysis showed that | 24 |
protein expression in | 24 |
the existence of | 24 |
the prevention of | 24 |
a range of | 24 |
is an uncommon | 24 |
the clinical course | 24 |
of the donor | 24 |
is able to | 24 |
it is unclear | 24 |
did not affect | 24 |
of these cases | 24 |
use of the | 24 |
chronic myeloid leukemia | 24 |
as early as | 24 |
of patients received | 24 |
occur in the | 24 |
genes involved in | 24 |
early diagnosis and | 24 |
in patients after | 24 |
outcomes of patients | 24 |
a matched related | 24 |
wide range of | 24 |
allogeneic bone marrow | 24 |
as a novel | 24 |
high prevalence of | 24 |
incidence of agvhd | 24 |
can be considered | 24 |
evaluate the impact | 24 |
patients affected by | 24 |
year cumulative incidence | 24 |
median time for | 24 |
signs and symptoms | 24 |
significantly increased in | 24 |
a matched sibling | 24 |
with relapsed refractory | 24 |
of the innate | 24 |
intensity conditioning regimen | 24 |
majority of cases | 24 |
the patient has | 24 |
in one case | 24 |
patients were alive | 24 |
shown in figure | 24 |
our results indicate | 24 |
significant differences were | 24 |
better understanding of | 24 |
a years old | 24 |
heterozygous mutations in | 24 |
chemotherapy followed by | 24 |
can also be | 24 |
first case of | 24 |
were stained with | 24 |
were defined as | 24 |
of pts with | 24 |
goal of this | 24 |
compared to control | 24 |
used to treat | 23 |
this work was | 23 |
event free survival | 23 |
between and were | 23 |
a lack of | 23 |
lymph node biopsy | 23 |
conditioning regimen and | 23 |
and should be | 23 |
the proliferation of | 23 |
decrease in the | 23 |
inborn errors of | 23 |
is required to | 23 |
is important for | 23 |
after weeks of | 23 |
of at least | 23 |
we report on | 23 |
supported by the | 23 |
were identified as | 23 |
and risk factors | 23 |
patients were male | 23 |
the b cell | 23 |
time of days | 23 |
were not statistically | 23 |
patients were evaluated | 23 |
mg dl and | 23 |
using flow cytometry | 23 |
b and c | 23 |
whitney u test | 23 |
abstract already published | 23 |
group and in | 23 |
less than years | 23 |
risk of gvhd | 23 |
results of this | 23 |
was found between | 23 |
all but one | 23 |
region of the | 23 |
examination of the | 23 |
a myeloablative conditioning | 23 |
significant reduction of | 23 |
was added to | 23 |
of the primary | 23 |
high rates of | 23 |
and activation of | 23 |
in the il | 23 |
cd cd t | 23 |
complete blood count | 23 |
and marrow transplantation | 23 |
cell dose was | 23 |
was to compare | 23 |
the length of | 23 |
lymph node metastasis | 23 |
admitted to the | 23 |
were diagnosed as | 23 |
may be useful | 23 |
as compared with | 23 |
in vivo and | 23 |
the appearance of | 23 |
who had a | 23 |
in the analysis | 23 |
be effective in | 23 |
it is known | 23 |
allogeneic haematopoietic stem | 23 |
median time between | 23 |
the most effective | 23 |
and he was | 23 |
t cell subsets | 23 |
two of them | 23 |
of regulatory t | 23 |
graft failure was | 23 |
identified as a | 23 |
at different time | 23 |
at diagnosis and | 23 |
from a matched | 23 |
was also found | 23 |
a mean of | 23 |
hsct in patients | 23 |
invasive fungal infection | 23 |
in these cases | 23 |
compared with those | 23 |
no differences were | 23 |
with increased risk | 23 |
most common cause | 23 |
the inhibition of | 23 |
be used for | 23 |
the characteristics of | 23 |
present study was | 23 |
be considered for | 23 |
in high risk | 23 |
first report of | 23 |
renal cell carcinoma | 23 |
are at risk | 23 |
with a significant | 23 |
mechanism of action | 23 |
cell receptor excision | 23 |
objective is to | 23 |
used to assess | 23 |
the period of | 23 |
records of patients | 23 |
cells from the | 23 |
stage renal disease | 23 |
even in the | 23 |
age at hsct | 23 |
the emergence of | 23 |
and a median | 23 |
to neutrophil engraftment | 23 |
and the development | 23 |
chronic gvhd were | 23 |
on the use | 23 |
the in vivo | 23 |
mouse model of | 23 |
positive for cd | 23 |
this may be | 23 |
t cells that | 23 |
two patients were | 23 |
all patients in | 23 |
retrospective cohort study | 23 |
and to identify | 23 |
old woman with | 23 |
patients with ms | 23 |
is a safe | 23 |
in b cell | 23 |
one patient who | 23 |
compared to non | 23 |
in both patients | 23 |
we have developed | 23 |
as the first | 23 |
there were patients | 23 |
no signs of | 23 |
the pathophysiology of | 23 |
to test the | 23 |
we are currently | 23 |
the transcription factor | 23 |
patients presented with | 23 |
he had a | 23 |
and patients were | 23 |
based on a | 23 |
of them received | 23 |
these patients had | 23 |
missense mutation in | 23 |
data from the | 23 |
alone or in | 23 |
data demonstrate that | 23 |
in cvid patients | 23 |
donor and recipient | 23 |
similar to those | 23 |
may be considered | 23 |
consecutive patients with | 23 |
positive correlation between | 23 |
should not be | 23 |
who had received | 23 |
of t and | 22 |
each of the | 22 |
essential for the | 22 |
average number of | 22 |
and negative for | 22 |
was not significant | 22 |
not been reported | 22 |
well tolerated and | 22 |
but it is | 22 |
been used for | 22 |
as an alternative | 22 |
key role in | 22 |
at the start | 22 |
the need of | 22 |
levels in the | 22 |
in multiple myeloma | 22 |
was approved by | 22 |
factors such as | 22 |
at day after | 22 |
poor graft function | 22 |
with common variable | 22 |
of herpes simplex | 22 |
median dose of | 22 |
age at the | 22 |
been previously reported | 22 |
was also observed | 22 |
did not find | 22 |
was performed at | 22 |
significant association between | 22 |
university hospital of | 22 |
in the human | 22 |
compared with control | 22 |
of follow up | 22 |
been found in | 22 |
who had undergone | 22 |
t and nk | 22 |
use of plerixafor | 22 |
dependent on the | 22 |
solid organ transplantation | 22 |
and it was | 22 |
not been previously | 22 |
the recruitment of | 22 |
are important for | 22 |
a central role | 22 |
in older patients | 22 |
time of transplantation | 22 |
and risk of | 22 |
adoptive transfer of | 22 |
of cd in | 22 |
function mutations in | 22 |
he was started | 22 |
early in life | 22 |
of relapse and | 22 |
source was peripheral | 22 |
that patients with | 22 |
kg cd cells | 22 |
related or unrelated | 22 |
in the left | 22 |
transplanted in cr | 22 |
yet to be | 22 |
is found in | 22 |
immune response in | 22 |
were retrospectively analyzed | 22 |
study suggests that | 22 |
up to years | 22 |
achieved complete remission | 22 |
one of these | 22 |
levels were significantly | 22 |
crucial role in | 22 |
b cells are | 22 |
was diagnosed as | 22 |
in the pre | 22 |
none of these | 22 |
we retrospectively evaluated | 22 |
the group with | 22 |
was started at | 22 |
did not develop | 22 |
many of the | 22 |
been used to | 22 |
patients with an | 22 |
old man with | 22 |
haploidentical hematopoietic stem | 22 |
bone marrow was | 22 |
occurred in of | 22 |
day and day | 22 |
clinical manifestations of | 22 |
three patients had | 22 |
to those of | 22 |
the multivariate analysis | 22 |
patients were divided | 22 |
and in vitro | 22 |
it was shown | 22 |
a better understanding | 22 |
months after the | 22 |
on the presence | 22 |
identification of the | 22 |
prospective studies are | 22 |
is related to | 22 |
significantly correlated with | 22 |
cells were isolated | 22 |
more than years | 22 |
performed in the | 22 |
of patients receiving | 22 |
of high risk | 22 |
were analyzed for | 22 |
should be performed | 22 |
significant reduction in | 22 |
subset of patients | 22 |
was higher than | 22 |
after completion of | 22 |
did not respond | 22 |
in the upper | 22 |
survival rate was | 22 |
the first patient | 22 |
p and p | 22 |
of immune suppression | 22 |
of the pts | 22 |
compared to a | 22 |
result in a | 22 |
of cd b | 22 |
free survival was | 22 |
for this study | 22 |
has been proposed | 22 |
high risk for | 22 |
acute respiratory syndrome | 22 |
from an hla | 22 |
is a novel | 22 |
this study aimed | 22 |
there are few | 22 |
lymphoblastoid cell lines | 22 |
have also been | 22 |
based on clinical | 22 |
referred to the | 22 |
group and the | 22 |
expression of p | 22 |
prevention and treatment | 22 |
is critical for | 22 |
had to be | 22 |
in any of | 22 |
expression of il | 22 |
innate immune system | 22 |
and flow cytometry | 22 |
percentage of patients | 22 |
were performed on | 22 |
s p ratio | 22 |
and to determine | 22 |
human monoclonal antibodies | 22 |
efficacy of the | 22 |
patients with hematologic | 22 |
percent of patients | 22 |
and of patients | 22 |
adolescents and young | 22 |
we used the | 22 |
viral load in | 22 |
most of them | 22 |
were analyzed in | 22 |
may also be | 22 |
associated hemophagocytic syndrome | 22 |
the molecular mechanisms | 22 |
is not clear | 22 |
days after transplantation | 22 |
lower in the | 22 |
complication of allogeneic | 21 |
effector t cells | 21 |
only curative treatment | 21 |
to be involved | 21 |
are consistent with | 21 |
and loss of | 21 |
in the expression | 21 |
a paucity of | 21 |
time to platelet | 21 |
from bone marrow | 21 |
large number of | 21 |
department of hematology | 21 |
to control the | 21 |
insights into the | 21 |
to estimate the | 21 |
between and in | 21 |
infection of the | 21 |
conditioning regimen in | 21 |
group a and | 21 |
with an average | 21 |
large cohort of | 21 |
analysis of patients | 21 |
she had a | 21 |
an extremely rare | 21 |
reported in patients | 21 |
in at least | 21 |
in colorectal cancer | 21 |
cmv reactivation was | 21 |
the beginning of | 21 |
defined as a | 21 |
linked to the | 21 |
risk of infection | 21 |
gvhd grade ii | 21 |
were assessed by | 21 |
lost to follow | 21 |
with acute gvhd | 21 |
low incidence of | 21 |
stem cells from | 21 |
engraftment was achieved | 21 |
but there was | 21 |
was due to | 21 |
is an autosomal | 21 |
with a low | 21 |
levels of the | 21 |
cells and a | 21 |
was similar in | 21 |
as stem cell | 21 |
and of them | 21 |
of a year | 21 |
is a severe | 21 |
and could be | 21 |
in a pediatric | 21 |
of t lymphocytes | 21 |
characteristics of patients | 21 |
the prognosis of | 21 |
surface expression of | 21 |
of cd on | 21 |
at any time | 21 |
who were diagnosed | 21 |
with the addition | 21 |
peripheral blood and | 21 |
is necessary to | 21 |
the feasibility of | 21 |
in a significant | 21 |
one hundred and | 21 |
the patient presented | 21 |
to have an | 21 |
our center between | 21 |
performed using the | 21 |
acute respiratory distress | 21 |
plasma levels of | 21 |
part of a | 21 |
of mg dl | 21 |
in spite of | 21 |
had a history | 21 |
the patient developed | 21 |
and fungal infections | 21 |
objective was to | 21 |
treatment for patients | 21 |
mantle cell lymphoma | 21 |
identification of a | 21 |
who were treated | 21 |
the frequency and | 21 |
no difference between | 21 |
in a prospective | 21 |
in the spleen | 21 |
on the cell | 21 |
memory b cell | 21 |
these findings suggest | 21 |
in mm patients | 21 |
respiratory distress syndrome | 21 |
difference was not | 21 |
in about of | 21 |
for detection of | 21 |
t cell function | 21 |
was lower in | 21 |
increased in the | 21 |
incidence of cmv | 21 |
after stimulation with | 21 |
increase the risk | 21 |
were measured in | 21 |
correlation was found | 21 |
our center from | 21 |
is likely to | 21 |
the normal range | 21 |
of the main | 21 |
in the multivariate | 21 |
the clinical presentation | 21 |
not show any | 21 |
with hematologic malignancies | 21 |
were performed with | 21 |
retrospectively analyzed the | 21 |
positive and negative | 21 |
of cd l | 21 |
we used a | 21 |
these results are | 21 |
prognostic significance of | 21 |
period of time | 21 |
especially in the | 21 |
gvhd prophylaxis in | 21 |
the need to | 21 |
body mass index | 21 |
children with cancer | 21 |
the intensity of | 21 |
were excluded from | 21 |
associated with poor | 21 |
study shows that | 21 |
in a child | 21 |
patients with suspected | 21 |
to develop a | 21 |
of the brain | 21 |
in the transplant | 21 |
of severe acute | 21 |
hepatitis c virus | 21 |
patients with mds | 21 |
compared to that | 21 |
a heterogeneous group | 21 |
porcine reproductive and | 20 |
positively correlated with | 20 |
of the infection | 20 |
at mg kg | 20 |
from day to | 20 |
were consistent with | 20 |
leads to the | 20 |
high morbidity and | 20 |
we decided to | 20 |
disorder characterized by | 20 |
in the adult | 20 |
of care for | 20 |
a mouse model | 20 |
patients with cd | 20 |
median overall survival | 20 |
acute gvhd in | 20 |
reproductive and respiratory | 20 |
nk cells in | 20 |
at the onset | 20 |
to the cell | 20 |
who received hsct | 20 |
viral infections in | 20 |
to the presence | 20 |
for the entire | 20 |
its ability to | 20 |
based conditioning regimen | 20 |
human endogenous retrovirus | 20 |
of gd t | 20 |
higher rates of | 20 |
c bl mice | 20 |
in the cytoplasm | 20 |
the first day | 20 |
found in of | 20 |
was significantly increased | 20 |
four patients with | 20 |
this patient population | 20 |
was not different | 20 |
epstein barr virus | 20 |
in most patients | 20 |
included patients with | 20 |
might be a | 20 |
high expression of | 20 |
which is the | 20 |
and specificity of | 20 |
no cases of | 20 |
in subjects with | 20 |
pfs and os | 20 |
sequencing was performed | 20 |
a mean age | 20 |
was bone marrow | 20 |
in cd t | 20 |
a high rate | 20 |
curative option for | 20 |
were higher in | 20 |
and cd cell | 20 |
here we describe | 20 |
in the serum | 20 |
vast majority of | 20 |
this type of | 20 |
age at transplantation | 20 |
after treatment with | 20 |
patients with all | 20 |
for the study | 20 |
primary immune deficiencies | 20 |
be an effective | 20 |
b cell development | 20 |
year after hsct | 20 |
had no effect | 20 |
primary and metastatic | 20 |
the infusion of | 20 |
levels were measured | 20 |
graft failure and | 20 |
patients responded to | 20 |
to identify patients | 20 |
in the era | 20 |
cells in patients | 20 |
the vast majority | 20 |
were more frequent | 20 |
marrow biopsy was | 20 |
with cmv reactivation | 20 |
diagnosed with a | 20 |
at day was | 20 |
and western blot | 20 |
he presented with | 20 |
was extracted from | 20 |
based gvhd prophylaxis | 20 |
bone marrow aspirate | 20 |
in conjunction with | 20 |
the host immune | 20 |
of the graft | 20 |
due to an | 20 |
a retrospective cohort | 20 |
occurred at a | 20 |
mg kg d | 20 |
due to their | 20 |
was the only | 20 |
and grade iii | 20 |
and multivariate analysis | 20 |
and one with | 20 |
less than of | 20 |
observed in of | 20 |
of adult patients | 20 |
the liver and | 20 |
and is associated | 20 |
be explained by | 20 |
are characterized by | 20 |
case highlights the | 20 |
female with a | 20 |
with the exception | 20 |
of a single | 20 |
at diagnosis of | 20 |
relapse free survival | 20 |
is due to | 20 |
biological activity of | 20 |
cyclophosphamide mg kg | 20 |
for acute myeloid | 20 |
heterogeneous group of | 20 |
quality of the | 20 |
high frequency of | 20 |
the th percentile | 20 |
virus in the | 20 |
was related to | 20 |
and respiratory syndrome | 20 |
involvement of the | 20 |
year old female | 20 |
the era of | 20 |
patients transplanted from | 20 |
over the course | 20 |